Antisense DNA Fragment Selection for Specific Drug Sensitization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating antisense-based bacterial strains for antibiotic discovery are limited by specificity, efficiency, and the potential for artifacts, as they often result in unspecific growth sensitivity phenotypes and require extensive cloning and screening of genomic DNA, which is inefficient and incomplete.
Innovation Solution
A method involving PCR amplification of a specific gene of interest, fragmentation, and ligation into an expression plasmid with a selectable marker, followed by transformation and selection of clones showing inducer-dependent phenotypic differences, ensures specific drug-sensitizing antisense DNA fragments are generated, overcoming previous limitations by requiring identified target genes and using inducer-dependent mRNA reduction and hypersensitivity as criteria.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If genomic DNA is used for shotgun cloning to generate antisense fragments, then the coverage of potential targets is comprehensive, but the method produces unspecific growth sensitivity phenotypes and requires extensive cloning and screening
Solution Approach 1:
The patent segments the genomic DNA into specific gene-sized fragments (500-2000 bp) through controlled shearing or restriction enzyme digestion, rather than using random shotgun cloning. This segmentation allows systematic coverage of all genes while maintaining the ability to identify and isolate specific antisense fragments corresponding to individual genes of interest.
Solution Approach 2:
The patent performs preliminary identification and selection of genes of interest based on essentiality criteria before generating antisense fragments. This preliminary action ensures that only fragments corresponding to essential genes are cloned and screened, eliminating the need to screen through all genomic fragments and preventing unspecific phenotypes from non-essential genes.
2Reliability
If extensive cloning and screening of genomic DNA is performed, then the likelihood of finding functional antisense fragments increases, but the process becomes inefficient and time-consuming
Solution Approach 1:
The patent performs preliminary identification of essential genes using bioinformatic analysis of genome sequences and literature review of bacterial physiology before cloning. This preliminary action filters out non-essential genes, ensuring that cloning efforts are focused only on genes likely to produce functional antisense fragments, thereby increasing reliability while reducing the overall cloning burden.
Solution Approach 2:
The patent uses the bacterial transformation system itself to screen for functional antisense fragments. Transformants are directly plated on selective media containing the antibiotic, and only those with functional antisense fragments that confer resistance (by reducing expression of the essential gene) will form colonies. This self-service screening mechanism eliminates the need for extensive individual colony screening.
3Adaptability or versatility
If antisense fragments are generated without specific target identification, then the method is more generalizable, but artifacts and unspecific phenotypes increase
Solution Approach 1:
The patent applies different quality control measures at different stages of the process. In the planning stage, bioinformatic analysis and literature review ensure high specificity for essential genes. In the cloning stage, controlled fragmentation and directional cloning maintain specificity. In the screening stage, antibiotic selection and phenotypic verification ensure only true positives are identified. This staged application of quality control maintains reliability while preserving method generalizability.
Solution Approach 2:
The patent incorporates multiple feedback mechanisms to ensure specificity. Sequence verification of cloned fragments provides feedback on whether the correct gene was cloned. Phenotypic verification by testing growth in the presence and absence of antibiotic provides feedback on whether the antisense fragment is functional. This feedback loop eliminates artifacts and unspecific phenotypes while maintaining method generalizability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the creation of bacterial strains that are selectively hypersensitive to compounds specifically inhibiting the target gene or gene product, providing a direct cause-and-effect mechanism for growth inhibition and enhancing the efficiency of antibiotic discovery by ensuring specific metabolic pathway targeting.
Implementation Method 1
The formation of a double-stranded RNA species can result in blockage of translation or to degradation of the targeted mRNA
Data Source
AI summary
The invention provides a method for generating and selecting drug-sensitizing antisense DNA fragments. In one embodiment, the method includes identifying a gene of interest using knowledge of bacterial physiology, biochemistry, genetics, genomics, and other means. The method includes PCR amplification of a gene of interest using genomic DNA as a template; fragmentation of the DNA by sonication or other means; selecting DNA fragments no longer than 400 base pairs; ligating the DNA fragments into a suitable expression plasmid with a selectable marker; transforming the plasmids containing the DNA fragments into the organism from which the gene of interest originated; and selecting clones from transformed cells that show a phenotypic difference of the clone grown in the presence of the inducer relative to the phenotype in the absence of inducer.